Viewing Study NCT02712866


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-02-18 @ 1:02 AM
Study NCT ID: NCT02712866
Status: COMPLETED
Last Update Posted: 2019-02-28
First Post: 2016-03-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Early Biomarkers in Circulating α 4β7 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients.
Sponsor: Parc de Salut Mar
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-01
Start Date Type: ACTUAL
Primary Completion Date: 2019-02
Primary Completion Date Type: ACTUAL
Completion Date: 2019-02
Completion Date Type: ACTUAL
First Submit Date: 2016-03-14
First Submit QC Date: None
Study First Post Date: 2016-03-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-02-26
Last Update Post Date: 2019-02-28
Last Update Post Date Type: ACTUAL